The Bioequivalence Study of Acyclovir 800 mg Tablet in Healthy Thai Volunteers Under Fasting Conditions - Trial NCT06228430
Access comprehensive clinical trial information for NCT06228430 through Pure Global AI's free database. This Phase 1 trial is sponsored by International Bio service and is currently Not yet recruiting. The study focuses on Healthy Volunteer. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
International Bio service
Timeline & Enrollment
Phase 1
Feb 12, 2024
Feb 22, 2024
Primary Outcome
Plasma Area Under the Curve (AUC(0 to 36 Hour)) for Acyclovir,Peak Plasma Concentration (Cmax) of Acyclovir
Summary
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic
 Acyclovir 800 mg Tablet and Reference Product (Zoviraxโข) in Healthy Thai Volunteers under
 Fasting Conditions
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06228430
Non-Device Trial

